# Organo Sintesis, S.A. De C.V. - Inspection Records

Source: https://www.keypedia.com/companies/organo-sintesis-sa-de-cv/0d8f4d8d-0fbd-4c4a-8362-439c74e4f37d

> Inspection records and compliance data for Organo Sintesis, S.A. De C.V. in Capulhuac, None. Access full analysis and detailed observations.

---

## Details

- Name: Organo Sintesis, S.A. De C.V.
- FEI Number: 3000324304
- City: Capulhuac
- State: None
- Country Name: Mexico
- Address Line 1: Carretera Amomolulco a Santiago Tianguistenco Km 10.8, Aguablanca
- Zip Code: None

## Related Documents

- [483 - Organo Sintesis, S.A. De C.V. - Unknown Date](https://www.keypedia.com/records/483/organo-sintesis-sa-de-cv/ae41dde3-c578-4491-9eda-ec675b85df4f) — source: FDA, date: Invalid Date
- [483 - Organo Sintesis, S.A. De C.V. - 2023-07-28](https://www.keypedia.com/records/483/organo-sintesis-sa-de-cv/3cb743cb-3d32-4a19-9b78-c2bc8c6a8810) — source: FDA, date: July 28, 2023
- [FDA Inspection 1218259 - Organo Sintesis, S.A. De C.V. - 2023-07-28](https://www.keypedia.com/records/fda_inspections/organo-sintesis-sa-de-cv/4de42ed2-d325-42b0-b74a-0d0cf17f3aef) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 28, 2023
- [FDA Inspection 995619 - Organo Sintesis, S.A. De C.V. - 2016-08-05](https://www.keypedia.com/records/fda_inspections/organo-sintesis-sa-de-cv/de0b7371-aef0-4d96-b35d-040d587c0c4a) — classification: No Action Indicated (NAI), source: FDA, date: August 5, 2016
- [FDA Inspection 809281 - Organo Sintesis, S.A. De C.V. - 2012-10-25](https://www.keypedia.com/records/fda_inspections/organo-sintesis-sa-de-cv/f28dfcfa-6a16-4fdb-9aa2-31aa747f2103) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 25, 2012

## Related Companies

- [Lonza Biologics, Inc.](https://www.keypedia.com/companies/lonza-biologics-inc/f9882ce5-d92a-4c88-916e-8f4e6d1f2aff)
- [Biogen MA Inc.](https://www.keypedia.com/companies/biogen-ma-inc/85b778d2-1e69-485d-9e93-05c656646fa2)
- [GlaxoSmithKline dba Human Genome Sciences Inc](https://www.keypedia.com/companies/glaxosmithkline-dba-human-genome-sciences-inc/c3dd2e54-125d-4d56-b0dc-18cb333074cc)
- [Solara Active Pharma Sciences Limited](https://www.keypedia.com/companies/solara-active-pharma-sciences-limited/8f3f8236-f49d-43e3-84af-2cb404fb8264)
- [Bachem Americas, Inc.](https://www.keypedia.com/companies/bachem-americas-inc/f0157d2d-6b0c-4b13-afd4-551c2ab94aad)
- [UQUIFA Mexico, S.A. de C.V.](https://www.keypedia.com/companies/uquifa-mexico-sa-de-cv/8523a240-e52a-495e-a781-e12c6412dc69)
- [Spark Therapeutics, Inc.](https://www.keypedia.com/companies/spark-therapeutics-inc/a5518493-a117-41d3-862d-96d5a5d3b6dd)
- [MSN Laboratories Private Limited, Unit-II](https://www.keypedia.com/companies/msn-laboratories-private-limited-unit-ii/539d7af5-94e6-4abe-b01b-fa911be84d2a)
- [AGILENT TECHNOLOGIES INC./US](https://www.keypedia.com/companies/agilent-technologies-incus/f39880d4-233e-44bc-9a9e-56d1f9b48065)
- [Lonza AG](https://www.keypedia.com/companies/lonza-ag/7084f7e6-ce36-429f-942a-28e759416e70)

## Related Officers

- [Investigator](https://www.keypedia.com/people/muna-algharibeh/0f0dbd13-b36a-408d-8e42-4625f8de905d)
- [Claudia Perez-Kamarski](https://www.keypedia.com/people/claudia-perez-kamarski/b7020978-e2e4-43b0-b2c6-eb861a1a85d0)
- [investigator](https://www.keypedia.com/people/amir-alavi/d7179128-eb3f-489e-97cf-e2c5e5539a00)
- [Claudia Perez-Kass](https://www.keypedia.com/people/claudia-perez-kass/1e36fc79-1300-4a3b-b90e-ce1d3ec84670)